glp 1 agonists addiction GLP-1 medications are getting attention for their potential in care. Here's what the research is finding. #AddictionTreatment #GLP1 #EmergingResearch GLP-1 receptor agonists in addiction

W., Talebian, M., Fares, J., & Lesniak, M

The winner will depend on Phase 3 data, tolerability, approval timing, label breadth, payer access, and real-world persistence

It has been theorized that the chemicals in coffee enemas cause free radicals to be absorbed by the sulfhydryl (-SH) groups of glutathione in the bile, which thereafter become bile salts that are flushed out of the gall bladder [20]

It has shown significant promise as an effective intervention against type 2 diabetes (T2D) and excessive body weight, resulting in the United States Food and Drug Administration (FDA) approving its use against both conditions in May 2022 for T2D and November 2023 for obesity